Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.

WENDTNER CM;HILLMEN P;MAHADEVAN D;BÜHLER A;UHAREK L;COUTRÉ S;FRANKFURT O;BLOOR A;BOSCH F;FURMAN RR;KIMBY E;GRIBBEN JG;GOBBI, MARCO;DREISBACH L;HURD DD;SEKERES MA;FERRAJOLI A;SHAH S;ZHANG J;MOUTOUH DE PARSEVAL L;HALLEK M;HEEREMA NA;STILGENBAUER S;CHANAN KHAN AA

2011-01-01